Congressional marijuana provisions; DEA psychedelic quotas; FL AG: Keep legalization off ballot; Industry group’s Trump PAC donations
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.
If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
The House and Senate Appropriations Committees released a negotiated funding bill that continues a rider protecting state medical cannabis programs from federal interference and deletes a House provision that would have blocked the Trump administration from rescheduling marijuana.
The Drug Enforcement Administration said in a new filing that the marijuana rescheduling appeal process is still on hold and “remains pending” despite President Donald Trump’s executive order directing the attorney general to complete the reform “in the most expeditious manner.”
The Drug Enforcement Administration is moving to further increase legal production quotas in 2026 for psychedelics like psilocybin and DMT to be used in research.
Florida Attorney General James Uthmeier (R) and several business and anti-marijuana groups filed briefs asking the state Supreme Court to block a cannabis legalization initiative from appearing on the November ballot.
New Federal Election Commission filings show that the marijuana industry-funded American Rights and Reform PAC gave an additional $1.05 million to President Donald Trump’s MAGA Inc. super PAC before he signed a cannabis rescheduling executive order—on top of the $1 million it gave earlier last year.
Sen. Rick Scott (R-FL) told Marijuana Moment that he opposes President Donald Trump’s marijuana rescheduling executive order—claiming that cannabis is a “gateway drug” and saying his position is informed by the fact that his brother died from a drug overdose.
/ FEDERAL
Vice President JD Vance pushed back on claims that U.S. actions in Venezuela have “nothing to do with drugs because most of the fentanyl comes from elsewhere.”
Supreme Court Chief Justice John Roberts noted in his annual report that filings for defendants charged with federal drug offenses fell six percent in 2025.
Sen. Amy Klobuchar (D-MN) tweeted, “I visited Wild State Cider in Duluth to highlight why the hemp ban doesn’t work — threatening 2,700 MN jobs and hurting farmers and small businesses across our state. I’m working across the aisle to support responsible hemp businesses that strengthen our economy.”
/ STATES
An Indiana representative introduced a bill to legalize marijuana possession.
An Alabama representative filed a bill to increase penalties for people who use marijuana in vehicles with children present.
A Pennsylvania senator tweeted, “As we head into 2026, Pennsylvania faces familiar budget challenges—while a major revenue source sits idle. Cannabis is already here. It’s time for responsible regulation that generates revenue, protects consumers, and strengthens our economy.”
Florida regulators adopted changes to medical cannabis advertising and marketing rules.
The California Highway Patrol is accepting applications for a cannabis revenue-funded grant program supporting efforts to reduce impaired driving.
The New Hampshire Therapeutic Cannabis Medical Oversight Board will meet on Wednesday.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ INTERNATIONAL
Saudi Arabian officials executed a record number of people in 2025, most of whom were convicted of drug-related offenses.
/ SCIENCE & HEALTH
A review concluded that “several observational studies have reported that cannabis helped to reduce endometriosis-associated pain.”
A study found that “magnesium increases cannabinoid and terpene production in cannabis plants.”
A review concluded that evidence “suggests psilocybin may benefit geriatric depression” and “may theoretically reduce loneliness through enhanced social connectedness.”
/ BUSINESS
Wyld is acquiring Grön.
Curaleaf Holdings, Inc.’s chief legal officer established an automatic securities disposition plan.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
